Download Files:
GSK 224876
Price range: 2,672 CAD through 4,480 CAD
Products Details
Product Description
– GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects.
Web ID
– T27442
Storage Temperature
– -20℃
Shipping
– Blue Ice
Molecular Formula
– C20H17ClN3O3P
References
– Margolis DA, Eron JJ, DeJesus E, White S, Wannamaker P, Stancil B, Johnson M. Unexpected finding of delayed-onset seizures in HIV-positive, treatment-experienced subjects in the Phase IIb evaluation of fosdevirine (GSK2248761). Antivir Ther. 2014;19(1):69-78. doi: 10.3851/IMP2689. Epub 2013 Oct 24. PubMed PMID: 24158593.
CAS Number
– 1097733-15-7
Molecular Weight
– C20H17ClN3O3P
SMILES
– CC1=CC(P(C2=C(C(N)=O)NC3=CC=C(Cl)C=C23)(OC)=O)=CC(/C=C/C#N)=C1
Pathway
– Others
Product type
– Small Compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
Related Products
1000 in stock
1000 in stock
1000 in stock
